#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=[0002] The detection of particular DNA sequences in biological samples plays a decisive role in the area of molecular biology.
1-1	0-1	[	_	_	
1-2	1-5	0002	_	_	
1-3	5-6	]	_	_	
1-4	7-10	The	_	_	
1-5	11-20	detection	_	_	
1-6	21-23	of	_	_	
1-7	24-34	particular	_	_	
1-8	35-38	DNA	_	_	
1-9	39-48	sequences	_	_	
1-10	49-51	in	_	_	
1-11	52-62	biological	_	_	
1-12	63-70	samples	_	_	
1-13	71-76	plays	_	_	
1-14	77-78	a	_	_	
1-15	79-87	decisive	_	_	
1-16	88-92	role	_	_	
1-17	93-95	in	_	_	
1-18	96-99	the	_	_	
1-19	100-104	area	_	_	
1-20	105-107	of	_	_	
1-21	108-117	molecular	_	_	
1-22	118-125	biology	_	_	
1-23	125-126	.	_	_	

#Text=For example, in human and veterinary medical practice numerous infections are diagnosed by the detection of pathogen-specific DNA sequences.
2-1	127-130	For	_	_	
2-2	131-138	example	_	_	
2-3	138-139	,	_	_	
2-4	140-142	in	_	_	
2-5	143-148	human	_	_	
2-6	149-152	and	_	_	
2-7	153-163	veterinary	_	_	
2-8	164-171	medical	_	_	
2-9	172-180	practice	_	_	
2-10	181-189	numerous	_	_	
2-11	190-200	infections	_	_	
2-12	201-204	are	_	_	
2-13	205-214	diagnosed	_	_	
2-14	215-217	by	_	_	
2-15	218-221	the	_	_	
2-16	222-231	detection	_	_	
2-17	232-234	of	_	_	
2-18	235-252	pathogen-specific	_	_	
2-19	253-256	DNA	_	_	
2-20	257-266	sequences	_	_	
2-21	266-267	.	_	_	

#Text=Furthermore, methods for detecting particular DNA sequences are also used in the identification of genetic variants of particular human genes.
3-1	268-279	Furthermore	_	_	
3-2	279-280	,	_	_	
3-3	281-288	methods	_	_	
3-4	289-292	for	_	_	
3-5	293-302	detecting	_	_	
3-6	303-313	particular	_	_	
3-7	314-317	DNA	_	_	
3-8	318-327	sequences	_	_	
3-9	328-331	are	_	_	
3-10	332-336	also	_	_	
3-11	337-341	used	_	_	
3-12	342-344	in	_	_	
3-13	345-348	the	_	_	
3-14	349-363	identification	_	_	
3-15	364-366	of	_	_	
3-16	367-374	genetic	_	_	
3-17	375-383	variants	_	_	
3-18	384-386	of	_	_	
3-19	387-397	particular	_	_	
3-20	398-403	human	_	_	
3-21	404-409	genes	_	_	
3-22	409-410	.	_	_	

#Text=These genetic variants can be used as markers for the course of the disease and for the therapeutic response in a number of diseases, e.g. in psychiatric and neurological diseases.
#Text=[0003] Usually, for detecting DNA sequences in pathogen diagnostics, amplification techniques are used, for example PCR or RT-PCR, in order to increase the quantity of pathogen-specific DNA contained in the sample.
4-1	411-416	These	_	_	
4-2	417-424	genetic	_	_	
4-3	425-433	variants	_	_	
4-4	434-437	can	_	_	
4-5	438-440	be	_	_	
4-6	441-445	used	_	_	
4-7	446-448	as	_	_	
4-8	449-456	markers	_	_	
4-9	457-460	for	_	_	
4-10	461-464	the	_	_	
4-11	465-471	course	_	_	
4-12	472-474	of	_	_	
4-13	475-478	the	_	_	
4-14	479-486	disease	_	_	
4-15	487-490	and	_	_	
4-16	491-494	for	_	_	
4-17	495-498	the	_	_	
4-18	499-510	therapeutic	_	_	
4-19	511-519	response	_	_	
4-20	520-522	in	_	_	
4-21	523-524	a	_	_	
4-22	525-531	number	_	_	
4-23	532-534	of	_	_	
4-24	535-543	diseases	_	_	
4-25	543-544	,	_	_	
4-26	545-548	e.g	_	_	
4-27	548-549	.	_	_	
4-28	550-552	in	_	_	
4-29	553-564	psychiatric	_	_	
4-30	565-568	and	_	_	
4-31	569-581	neurological	_	_	
4-32	582-590	diseases	_	_	
4-33	590-591	.	_	_	
4-34	592-593	[	_	_	
4-35	593-597	0003	_	_	
4-36	597-598	]	_	_	
4-37	599-606	Usually	_	_	
4-38	606-607	,	_	_	
4-39	608-611	for	_	_	
4-40	612-621	detecting	_	_	
4-41	622-625	DNA	_	_	
4-42	626-635	sequences	_	_	
4-43	636-638	in	_	_	
4-44	639-647	pathogen	_	_	
4-45	648-659	diagnostics	_	_	
4-46	659-660	,	_	_	
4-47	661-674	amplification	_	_	
4-48	675-685	techniques	_	_	
4-49	686-689	are	_	_	
4-50	690-694	used	_	_	
4-51	694-695	,	_	_	
4-52	696-699	for	_	_	
4-53	700-707	example	_	_	
4-54	708-711	PCR	_	_	
4-55	712-714	or	_	_	
4-56	715-721	RT-PCR	_	_	
4-57	721-722	,	_	_	
4-58	723-725	in	_	_	
4-59	726-731	order	_	_	
4-60	732-734	to	_	_	
4-61	735-743	increase	_	_	
4-62	744-747	the	_	_	
4-63	748-756	quantity	_	_	
4-64	757-759	of	_	_	
4-65	760-777	pathogen-specific	_	_	
4-66	778-781	DNA	_	_	
4-67	782-791	contained	_	_	
4-68	792-794	in	_	_	
4-69	795-798	the	_	_	
4-70	799-805	sample	_	_	
4-71	805-806	.	_	_	

#Text=In a first step, usually a DNA purification is carried out starting from the respective patient sample (for example blood, serum, tissue, or the like).
5-1	807-809	In	_	_	
5-2	810-811	a	_	_	
5-3	812-817	first	_	_	
5-4	818-822	step	_	_	
5-5	822-823	,	_	_	
5-6	824-831	usually	_	_	
5-7	832-833	a	_	_	
5-8	834-837	DNA	_	_	
5-9	838-850	purification	_	_	
5-10	851-853	is	_	_	
5-11	854-861	carried	_	_	
5-12	862-865	out	_	_	
5-13	866-874	starting	_	_	
5-14	875-879	from	_	_	
5-15	880-883	the	_	_	
5-16	884-894	respective	_	_	
5-17	895-902	patient	_	_	
5-18	903-909	sample	_	_	
5-19	910-911	(	_	_	
5-20	911-914	for	_	_	
5-21	915-922	example	_	_	
5-22	923-928	blood	_	_	
5-23	928-929	,	_	_	
5-24	930-935	serum	_	_	
5-25	935-936	,	_	_	
5-26	937-943	tissue	_	_	
5-27	943-944	,	_	_	
5-28	945-947	or	_	_	
5-29	948-951	the	_	_	
5-30	952-956	like	_	_	
5-31	956-957	)	_	_	
5-32	957-958	.	_	_	

#Text=Depending on the nature of pathogen to be detected, the purified DNA can be obtained from bacterial cells or from cells of the affected tissue of the patient in question (e.g. in the case of infection with viruses whose DNA integrates into the genomic DNA of the infected host cells).
6-1	959-968	Depending	_	_	
6-2	969-971	on	_	_	
6-3	972-975	the	_	_	
6-4	976-982	nature	_	_	
6-5	983-985	of	_	_	
6-6	986-994	pathogen	_	_	
6-7	995-997	to	_	_	
6-8	998-1000	be	_	_	
6-9	1001-1009	detected	_	_	
6-10	1009-1010	,	_	_	
6-11	1011-1014	the	_	_	
6-12	1015-1023	purified	_	_	
6-13	1024-1027	DNA	_	_	
6-14	1028-1031	can	_	_	
6-15	1032-1034	be	_	_	
6-16	1035-1043	obtained	_	_	
6-17	1044-1048	from	_	_	
6-18	1049-1058	bacterial	_	_	
6-19	1059-1064	cells	_	_	
6-20	1065-1067	or	_	_	
6-21	1068-1072	from	_	_	
6-22	1073-1078	cells	_	_	
6-23	1079-1081	of	_	_	
6-24	1082-1085	the	_	_	
6-25	1086-1094	affected	_	_	
6-26	1095-1101	tissue	_	_	
6-27	1102-1104	of	_	_	
6-28	1105-1108	the	_	_	
6-29	1109-1116	patient	_	_	
6-30	1117-1119	in	_	_	
6-31	1120-1128	question	_	_	
6-32	1129-1130	(	_	_	
6-33	1130-1133	e.g	_	_	
6-34	1133-1134	.	_	_	
6-35	1135-1137	in	_	_	
6-36	1138-1141	the	_	_	
6-37	1142-1146	case	_	_	
6-38	1147-1149	of	_	_	
6-39	1150-1159	infection	_	_	
6-40	1160-1164	with	_	_	
6-41	1165-1172	viruses	_	_	
6-42	1173-1178	whose	_	_	
6-43	1179-1182	DNA	_	_	
6-44	1183-1193	integrates	_	_	
6-45	1194-1198	into	_	_	
6-46	1199-1202	the	_	_	
6-47	1203-1210	genomic	_	_	
6-48	1211-1214	DNA	_	_	
6-49	1215-1217	of	_	_	
6-50	1218-1221	the	_	_	
6-51	1222-1230	infected	_	_	
6-52	1231-1235	host	_	_	
6-53	1236-1241	cells	_	_	
6-54	1241-1242	)	_	_	
6-55	1242-1243	.	_	_	

#Text=The purified DNA can then be used in the respective amplification method, using primers that are specific with respect to their sequence to the pathogen to be detected.
#Text=[0004] Another possibility for the detection of pathogen-specific DNA sequences is offered by DNA hybridization methods, in which the presence of a defined DNA sequence is detected by hybridization with labeled probes.
7-1	1244-1247	The	_	_	
7-2	1248-1256	purified	_	_	
7-3	1257-1260	DNA	_	_	
7-4	1261-1264	can	_	_	
7-5	1265-1269	then	_	_	
7-6	1270-1272	be	_	_	
7-7	1273-1277	used	_	_	
7-8	1278-1280	in	_	_	
7-9	1281-1284	the	_	_	
7-10	1285-1295	respective	_	_	
7-11	1296-1309	amplification	_	_	
7-12	1310-1316	method	_	_	
7-13	1316-1317	,	_	_	
7-14	1318-1323	using	_	_	
7-15	1324-1331	primers	_	_	
7-16	1332-1336	that	_	_	
7-17	1337-1340	are	_	_	
7-18	1341-1349	specific	_	_	
7-19	1350-1354	with	_	_	
7-20	1355-1362	respect	_	_	
7-21	1363-1365	to	_	_	
7-22	1366-1371	their	_	_	
7-23	1372-1380	sequence	_	_	
7-24	1381-1383	to	_	_	
7-25	1384-1387	the	_	_	
7-26	1388-1396	pathogen	_	_	
7-27	1397-1399	to	_	_	
7-28	1400-1402	be	_	_	
7-29	1403-1411	detected	_	_	
7-30	1411-1412	.	_	_	
7-31	1413-1414	[	_	_	
7-32	1414-1418	0004	_	_	
7-33	1418-1419	]	_	_	
7-34	1420-1427	Another	_	_	
7-35	1428-1439	possibility	_	_	
7-36	1440-1443	for	_	_	
7-37	1444-1447	the	_	_	
7-38	1448-1457	detection	_	_	
7-39	1458-1460	of	_	_	
7-40	1461-1478	pathogen-specific	_	_	
7-41	1479-1482	DNA	_	_	
7-42	1483-1492	sequences	_	_	
7-43	1493-1495	is	_	_	
7-44	1496-1503	offered	_	_	
7-45	1504-1506	by	_	_	
7-46	1507-1510	DNA	_	_	
7-47	1511-1524	hybridization	_	_	
7-48	1525-1532	methods	_	_	
7-49	1532-1533	,	_	_	
7-50	1534-1536	in	_	_	
7-51	1537-1542	which	_	_	
7-52	1543-1546	the	_	_	
7-53	1547-1555	presence	_	_	
7-54	1556-1558	of	_	_	
7-55	1559-1560	a	_	_	
7-56	1561-1568	defined	_	_	
7-57	1569-1572	DNA	_	_	
7-58	1573-1581	sequence	_	_	
7-59	1582-1584	is	_	_	
7-60	1585-1593	detected	_	_	
7-61	1594-1596	by	_	_	
7-62	1597-1610	hybridization	_	_	
7-63	1611-1615	with	_	_	
7-64	1616-1623	labeled	_	_	
7-65	1624-1630	probes	_	_	
7-66	1630-1631	.	_	_	

#Text=A classical way of carrying out DNA hybridization methods is Southern blotting.
8-1	1632-1633	A	_	_	
8-2	1634-1643	classical	_	_	
8-3	1644-1647	way	_	_	
8-4	1648-1650	of	_	_	
8-5	1651-1659	carrying	_	_	
8-6	1660-1663	out	_	_	
8-7	1664-1667	DNA	_	_	
8-8	1668-1681	hybridization	_	_	
8-9	1682-1689	methods	_	_	
8-10	1690-1692	is	_	_	
8-11	1693-1701	Southern	_	_	
8-12	1702-1710	blotting	_	_	
8-13	1710-1711	.	_	_	

#Text=In this method the DNA isolated from the cells or tissues is, after fragmentation with restriction endonucleases, separated by gel electrophoresis, transferred to a membrane (e.g. a nitro-cellulose or nylon membrane), immobilized and hybridized to an appropriately labeled oligonucleotide probe.
9-1	1712-1714	In	_	_	
9-2	1715-1719	this	_	_	
9-3	1720-1726	method	_	_	
9-4	1727-1730	the	_	_	
9-5	1731-1734	DNA	_	_	
9-6	1735-1743	isolated	_	_	
9-7	1744-1748	from	_	_	
9-8	1749-1752	the	_	_	
9-9	1753-1758	cells	_	_	
9-10	1759-1761	or	_	_	
9-11	1762-1769	tissues	_	_	
9-12	1770-1772	is	_	_	
9-13	1772-1773	,	_	_	
9-14	1774-1779	after	_	_	
9-15	1780-1793	fragmentation	_	_	
9-16	1794-1798	with	_	_	
9-17	1799-1810	restriction	_	_	
9-18	1811-1824	endonucleases	_	_	
9-19	1824-1825	,	_	_	
9-20	1826-1835	separated	_	_	
9-21	1836-1838	by	_	_	
9-22	1839-1842	gel	_	_	
9-23	1843-1858	electrophoresis	_	_	
9-24	1858-1859	,	_	_	
9-25	1860-1871	transferred	_	_	
9-26	1872-1874	to	_	_	
9-27	1875-1876	a	_	_	
9-28	1877-1885	membrane	_	_	
9-29	1886-1887	(	_	_	
9-30	1887-1890	e.g	_	_	
9-31	1890-1891	.	_	_	
9-32	1892-1893	a	_	_	
9-33	1894-1909	nitro-cellulose	_	_	
9-34	1910-1912	or	_	_	
9-35	1913-1918	nylon	_	_	
9-36	1919-1927	membrane	_	_	
9-37	1927-1928	)	_	_	
9-38	1928-1929	,	_	_	
9-39	1930-1941	immobilized	_	_	
9-40	1942-1945	and	_	_	
9-41	1946-1956	hybridized	_	_	
9-42	1957-1959	to	_	_	
9-43	1960-1962	an	_	_	
9-44	1963-1976	appropriately	_	_	
9-45	1977-1984	labeled	_	_	
9-46	1985-2000	oligonucleotide	_	_	
9-47	2001-2006	probe	_	_	
9-48	2006-2007	.	_	_	

#Text=As an alter-native, the isolated DNA can be put on a membrane directly and then hybridized (dot blot).
10-1	2008-2010	As	_	_	
10-2	2011-2013	an	_	_	
10-3	2014-2026	alter-native	_	_	
10-4	2026-2027	,	_	_	
10-5	2028-2031	the	_	_	
10-6	2032-2040	isolated	_	_	
10-7	2041-2044	DNA	_	_	
10-8	2045-2048	can	_	_	
10-9	2049-2051	be	_	_	
10-10	2052-2055	put	_	_	
10-11	2056-2058	on	_	_	
10-12	2059-2060	a	_	_	
10-13	2061-2069	membrane	_	_	
10-14	2070-2078	directly	_	_	
10-15	2079-2082	and	_	_	
10-16	2083-2087	then	_	_	
10-17	2088-2098	hybridized	_	_	
10-18	2099-2100	(	_	_	
10-19	2100-2103	dot	_	_	
10-20	2104-2108	blot	_	_	
10-21	2108-2109	)	_	_	
10-22	2109-2110	.	_	_	

#Text=Southern blotting is often employed for investigating gene rearrangements.
#Text=[0005] In addition to Southern blotting, in situ hybridization has also become established in pathogen diagnostics.
11-1	2111-2119	Southern	_	_	
11-2	2120-2128	blotting	_	_	
11-3	2129-2131	is	_	_	
11-4	2132-2137	often	_	_	
11-5	2138-2146	employed	_	_	
11-6	2147-2150	for	_	_	
11-7	2151-2164	investigating	_	_	
11-8	2165-2169	gene	_	_	
11-9	2170-2184	rearrangements	_	_	
11-10	2184-2185	.	_	_	
11-11	2186-2187	[	_	_	
11-12	2187-2191	0005	_	_	
11-13	2191-2192	]	_	_	
11-14	2193-2195	In	_	_	
11-15	2196-2204	addition	_	_	
11-16	2205-2207	to	_	_	
11-17	2208-2216	Southern	_	_	
11-18	2217-2225	blotting	_	_	
11-19	2225-2226	,	_	_	
11-20	2227-2229	in	_	_	
11-21	2230-2234	situ	_	_	
11-22	2235-2248	hybridization	_	_	
11-23	2249-2252	has	_	_	
11-24	2253-2257	also	_	_	
11-25	2258-2264	become	_	_	
11-26	2265-2276	established	_	_	
11-27	2277-2279	in	_	_	
11-28	2280-2288	pathogen	_	_	
11-29	2289-2300	diagnostics	_	_	
11-30	2300-2301	.	_	_	

#Text=In situ hybridization means the direct detection of nucleic acid sequences in sections and cell preparations using suitable probes.
12-1	2302-2304	In	*[1]	13-1[2_1]	
12-2	2305-2309	situ	*[1]	_	
12-3	2310-2323	hybridization	*[1]	_	
12-4	2324-2329	means	*[1]	_	
12-5	2330-2333	the	*[1]	_	
12-6	2334-2340	direct	*[1]	_	
12-7	2341-2350	detection	*[1]	_	
12-8	2351-2353	of	*[1]	_	
12-9	2354-2361	nucleic	*[1]	_	
12-10	2362-2366	acid	*[1]	_	
12-11	2367-2376	sequences	*[1]	_	
12-12	2377-2379	in	*[1]	_	
12-13	2380-2388	sections	*[1]	_	
12-14	2389-2392	and	*[1]	_	
12-15	2393-2397	cell	*[1]	_	
12-16	2398-2410	preparations	*[1]	_	
12-17	2411-2416	using	*[1]	_	
12-18	2417-2425	suitable	*[1]	_	
12-19	2426-2432	probes	*[1]	_	
12-20	2432-2433	.	*[1]	_	

#Text=This method is already used in many laboratories for detecting viral DNA (cytomegalovirus, herpesviruses, etc.) in tissue sections and in cells.
13-1	2434-2438	This	*[2]	_	
13-2	2439-2445	method	*[2]	_	
13-3	2446-2448	is	_	_	
13-4	2449-2456	already	_	_	
13-5	2457-2461	used	_	_	
13-6	2462-2464	in	_	_	
13-7	2465-2469	many	_	_	
13-8	2470-2482	laboratories	_	_	
13-9	2483-2486	for	_	_	
13-10	2487-2496	detecting	_	_	
13-11	2497-2502	viral	_	_	
13-12	2503-2506	DNA	_	_	
13-13	2507-2508	(	_	_	
13-14	2508-2523	cytomegalovirus	_	_	
13-15	2523-2524	,	_	_	
13-16	2525-2538	herpesviruses	_	_	
13-17	2538-2539	,	_	_	
13-18	2540-2543	etc	_	_	
13-19	2543-2544	.	_	_	
13-20	2544-2545	)	_	_	
13-21	2546-2548	in	_	_	
13-22	2549-2555	tissue	_	_	
13-23	2556-2564	sections	_	_	
13-24	2565-2568	and	_	_	
13-25	2569-2571	in	_	_	
13-26	2572-2577	cells	_	_	
13-27	2577-2578	.	_	_	

#Text=In addition, the method can be used for the analysis of structural chromosomal changes.
#Text=[0006] The probes used in DNA hybridization methods can be labeled in various ways, for example with fluorescent molecules or with groups that can be detected immunologically from reaction with an antibody.
14-1	2579-2581	In	_	_	
14-2	2582-2590	addition	_	_	
14-3	2590-2591	,	_	_	
14-4	2592-2595	the	_	_	
14-5	2596-2602	method	_	_	
14-6	2603-2606	can	_	_	
14-7	2607-2609	be	_	_	
14-8	2610-2614	used	_	_	
14-9	2615-2618	for	_	_	
14-10	2619-2622	the	_	_	
14-11	2623-2631	analysis	_	_	
14-12	2632-2634	of	_	_	
14-13	2635-2645	structural	_	_	
14-14	2646-2657	chromosomal	_	_	
14-15	2658-2665	changes	_	_	
14-16	2665-2666	.	_	_	
14-17	2667-2668	[	_	_	
14-18	2668-2672	0006	_	_	
14-19	2672-2673	]	_	_	
14-20	2674-2677	The	_	_	
14-21	2678-2684	probes	_	_	
14-22	2685-2689	used	_	_	
14-23	2690-2692	in	_	_	
14-24	2693-2696	DNA	_	_	
14-25	2697-2710	hybridization	_	_	
14-26	2711-2718	methods	_	_	
14-27	2719-2722	can	_	_	
14-28	2723-2725	be	_	_	
14-29	2726-2733	labeled	_	_	
14-30	2734-2736	in	_	_	
14-31	2737-2744	various	_	_	
14-32	2745-2749	ways	_	_	
14-33	2749-2750	,	_	_	
14-34	2751-2754	for	_	_	
14-35	2755-2762	example	_	_	
14-36	2763-2767	with	_	_	
14-37	2768-2779	fluorescent	_	_	
14-38	2780-2789	molecules	_	_	
14-39	2790-2792	or	_	_	
14-40	2793-2797	with	_	_	
14-41	2798-2804	groups	_	_	
14-42	2805-2809	that	_	_	
14-43	2810-2813	can	_	_	
14-44	2814-2816	be	_	_	
14-45	2817-2825	detected	_	_	
14-46	2826-2841	immunologically	_	_	
14-47	2842-2846	from	_	_	
14-48	2847-2855	reaction	_	_	
14-49	2856-2860	with	_	_	
14-50	2861-2863	an	_	_	
14-51	2864-2872	antibody	_	_	
14-52	2872-2873	.	_	_	

#Text=Hybridization methods normally also require purification of the DNA to be investigated.
15-1	2874-2887	Hybridization	_	_	
15-2	2888-2895	methods	_	_	
15-3	2896-2904	normally	_	_	
15-4	2905-2909	also	_	_	
15-5	2910-2917	require	_	_	
15-6	2918-2930	purification	_	_	
15-7	2931-2933	of	_	_	
15-8	2934-2937	the	_	_	
15-9	2938-2941	DNA	_	_	
15-10	2942-2944	to	_	_	
15-11	2945-2947	be	_	_	
15-12	2948-2960	investigated	_	_	
15-13	2960-2961	.	_	_	
